Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Sept. 22, 2021, 7:35 a.m. EDT

CDC committee to meet today and Thursday to again discuss BioNTech and Pfizer's COVID-19 booster

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

A Centers for Disease Control and Prevention committee is set to meet Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE /zigman2/quotes/214419716/composite BNTX -0.81% and Pfizer Inc.'s /zigman2/quotes/202877789/composite PFE +0.53% COVID-19 booster shot. The CDC's Advisory Committee on Immunization Practices sets out the guidelines for how vaccines should be used in the U.S. The Food and Drug Administration has not approved or authorized an extra dose of the BioNTech and Pfizer vaccine except in people who are immuno-compromised, and an influential FDA committee last week recommended that boosters be limited to older people and those who are at higher risk of severe disease. Some experts have suggested that the FDA decision is coming this week.

/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 292.53
-2.39 -0.81%
Volume: 1.76M
Oct. 26, 2021 1:46p
P/E Ratio
15.40
Dividend Yield
N/A
Market Cap
$71.52 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 43.38
+0.23 +0.53%
Volume: 10.97M
Oct. 26, 2021 1:46p
P/E Ratio
18.63
Dividend Yield
3.59%
Market Cap
$241.93 billion
Rev. per Employee
$533,860
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.